Publications dans lesquelles il/elle collabore avec Carlos Rubio Terrés (1)

2021

  1. Cost of fremanezumab, erenumab, galcanezumab and onabotulinumtoxinA associated adverse events, for migraine prophylaxis in Spain

    Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 21, Núm. 2, pp. 285-297